Mushrooms and Colorectal Cancer: Unveiling Mechanistic Insights and Therapeutic Innovations
Phytotherapy Research · 2025-01 · 39 (1) · 480-493
DOI: 10.1002/ptr.8382 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 11.11.2024. Verfasst von Samridhi Kurl und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Drug Research, Punjabi University Patiala, Patiala, Punjab, India. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Agaricales, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: AICTE, All India Council for Technical Education.
Abstract (Originalsprache)
Nature has bestowed us with an abundant reservoir of resources that besides having nutritional value, are prolific mines of bioactive constituents with a plethora of medicinal activities. Mushrooms have been used since centuries in traditional system of medicine for their purported health benefits including anticancer activities. Thorough research, spanning over centuries in Japan, China, Korea, and the USA, has established the unique properties of mushrooms and their extractives in the prevention and treatment of various types cancer. The aim of the review article is to provide a comprehensive overview of the existing literature highlighting the potential relationship between mushrooms and colorectal cancer. Different databases such as PubMed, Web of Science, Google Scholar, and ScienceDirect were searched and a total of 62 articles and two book chapters were reviewed, and data were extracted. Multiple studies have demonstrated that mushrooms exhibit anticancer activities, effectively reducing adverse side effects such as nausea, myelosuppression, anemia, and sleeplessness. Furthermore, they have been shown to mitigate drug resistance following chemotherapy and radiation therapy. Certain species such as Antrodia , Pleurotus , Ganoderma , Lentinula , Hericium , Cantharellus , Clitocybe , Coprinopsis , Trametes , Sparassis , Lactarius , and so on manifest anticancer activity in colon. The article can help improve the scientific understanding of the co‐relationship between mushrooms and colorectal cancer. This may help in advancing the research directions and integrating the mushroom‐based strategies into current treatment protocols of colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Drug Research, Punjabi University Patiala, Patiala, Punjab, India.
- General William Polyclinic, Patiala, Punjab, India.
- Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
ORCID-Profile: Gurpreet Kaur
Förderung
- AICTE
- All India Council for Technical Education
Zitieren
APA
Kurl, S., Kaur, S., Mittal, N., & Kaur, G. (2025). Mushrooms and Colorectal Cancer: Unveiling Mechanistic Insights and Therapeutic Innovations. Phytotherapy Research, 39(1), 480-493. https://doi.org/10.1002/ptr.8382
Vancouver
Kurl S, Kaur S, Mittal N, Kaur G. Mushrooms and Colorectal Cancer: Unveiling Mechanistic Insights and Therapeutic Innovations. Phytotherapy Research. 2025;39(1):480-493. doi:10.1002/ptr.8382
BibTeX
@article{Kurl2025,
author = {Kurl, Samridhi and Kaur, Snimmer and Mittal, Neeraj and Kaur, Gurpreet},
title = {Mushrooms and Colorectal Cancer: Unveiling Mechanistic Insights and Therapeutic Innovations},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {1},
pages = {480--493},
doi = {10.1002/ptr.8382}
}
EUVIMED